A survey of cancer-associated mutations found in TRF1 and TRF2 at the cBioPortal for Cancer Genomics [25,26] reveals that none of them is located within TRF2 B domain, suggesting a strong counterselection against altered B domain variants. This evidence concerns the gene TERF1 and cancer.